Recent progress and clinical development of inhibitors that block MDM4/p53 protein–protein interactions

S Zhang, J Lou, Y Li, F Zhou, Z Yan… - Journal of Medicinal …, 2021 - ACS Publications
MDM4 is a homologue of MDM2, serving cooperatively as the negative regulator of tumor
suppressor p53. Under the shadow of MDM2 inhibitors, limited efforts had been put into the …

The long and the short of it: the MDM4 tail so far

S Haupt, JO Mejía-Hernández… - Journal of molecular …, 2019 - academic.oup.com
The mouse double minute 4 (MDM4) is emerging from the shadow of its more famous
relative MDM2 and is starting to steal the limelight, largely due to its therapeutic possibilities …

Targeting MDMX for cancer therapy: rationale, strategies, and challenges

DH Yu, ZY Xu, S Mo, L Yuan, XD Cheng… - Frontiers in …, 2020 - frontiersin.org
The oncogene MDMX, also known as MDM4 is a critical negative regulator of the tumor
suppressor p53 and has been implicated in the initiation and progression of human cancers …

Targeting the ubiquitin system in glioblastoma

N Scholz, KM Kurian, FA Siebzehnrubl… - Frontiers in …, 2020 - frontiersin.org
Glioblastoma is the most common primary brain tumor in adults with poor overall outcome
and 5-year survival of less than 5%. Treatment has not changed much in the last decade or …

The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review

H Jiang, J Luo, H Lei - Experimental Eye Research, 2022 - Elsevier
Abstract Mouse double minute 2 (MDM2), an E3 ubiquitin ligase and the primary negative
regulator of the tumor suppressor p53, cooperates with its structural homolog MDM4/MDMX …

The MDMX acidic domain uses allovalency to bind both p53 and MDMX

M Fenton, W Borcherds, L Chen, A Anbanandam… - Journal of molecular …, 2022 - Elsevier
Autoinhibition of p53 binding to MDMX requires two short-linear motifs (SLiMs) containing
adjacent tryptophan (WW) and tryptophan-phenylalanine (WF) residues. NMR spectroscopy …

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector

W Lin, Y Yan, Q Huang, D Zheng - Biologics: Targets and Therapy, 2024 - Taylor & Francis
The p53 tumor suppressor protein plays an important role in physiological and pathological
processes. MDM2 and its homolog MDMX are the most important negative regulators of p53 …

Cellular, Structural Basis, and Recent Progress for Targeting Murine Double Minute X (MDMX) in Tumors

Q Yin, Y Hu, Z Dong, J Lu, H Wang - Journal of Medicinal …, 2024 - ACS Publications
Murine double minute X (MDMX) is an oncoprotein that mainly has a negative regulatory
effect on the tumor suppressor p53 to induce tumorigenesis. As MDMX is highly expressed …

Synthesis, structural characterization and antitumor activity of six rare earth metal complexes with 8-hydroxyquinoline derivatives

QY Yang, QQ Cao, YL Zhang, XF Xu, CX Deng… - Journal of Inorganic …, 2020 - Elsevier
The rare earth metal Gd (III), Yb (III), Lu (III), Eu (III), Tb (III) and Ho (III) complexes 1–6 with 2-
((2-(pyridin-2-yl) hydrazono) methyl) quinolin-8-ol (HL) as ligands were synthesized. The in …

Hesperidin Inhibits the p53‐MDMXInteraction‐Induced Apoptosis of Non‐Small‐Cell Lung Cancer and Enhances the Antitumor Effect of Carboplatin

Y Feng, H Huo, Q Tang - Journal of Oncology, 2022 - Wiley Online Library
Objective. This study aimed to observe the effect of hesperidin on the apoptosis,
proliferation, and invasion of non‐small‐cell lung cancer, as well as to explore the possible …